¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sulfate reduction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • zinc sulfate
    ¾Æ¿¬È²»ê¿°
  • zinc sulfate flotation
    Ȳ»ê¾Æ¿¬ºÎÀ¯¹ý
  • barium reduction
    ¹Ù·ýÁ¤º¹(¼ú)
  • breast reduction
    À¯¹æÁÙÀÓ(¼ú), À¯¹æÃà¼Ò(¼ú)
  • closed reduction
    ºñ°³¹æÁ¤º¹(¼ú), Æó¼âÁ¤º¹(¼ú)
  • forehead reduction
    À̸¶Ãà¼Ò(¼ú), À̸¶¼ºÇü(¼ú)
  • false reduction
    °¡Á¤º¹, °¡È¯³³, °ÅÁþ¸ÂÃã
  • mandibular angle reduction
    ÅλÀ°¢Ãà¼Ò(¼ú), ÇϾǰ¢Ãà¼Ò(¼ú)
  • nitrate reduction
    Áú»ê¿°È¯¿ø
  • open reduction
    °³¹æÁ¤º¹(¼ú)
  • oxidation-reduction
    »êȭȯ¿ø
  • oxidation-reduction potential
    »êȭȯ¿øÀüÀ§
  • oxidation-reduction system
    »êȭȯ¿ø°è
  • proportional reduction
    ºñ·Ê°¨¼Ò
  • reduction
    1. ¸ÂÃã, ±³Á¤, Á¤º¹(¼ú) 2. ȯ¿ø 3. Ãà¼Ò(¼ú) 4. ¾àºÐ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • closed reduction
    Æó¼â°ñÀý±³Á¤, Æó¼âµÇ¸ÂÃã¼ú
  • egg reduction rate
    Ãæ¶õ°¨¼ÒÀ²
  • false reduction
    °¡Á¤º¹, °¡È¯³³, °ÅÁþ¸ÂÃã
  • forehead reduction
    À̸¶»è°¨¼ú, À̸¶¼ºÇü¼ú
  • mandibular angle reduction
    ÅλÀ°¢Ãà¼Ò¼ú, ÇϾǰ¢Ãà¼Ò¼ú
  • silver reduction method
    ÀºÈ¯¿ø¹ý
  • nitrate reduction
    Áú»ê¿°È¯¿ø
  • oxidation-reduction
    »êȭȯ¿ø
  • open reduction
    °³¹æ°ñÀý±³Á¤, ¿­¸²µÇ¸ÂÃã¼ú
  • oxidation-reduction potential
    »êȭȯ¿øÀüÀ§
  • oxidation-reduction system
    »êȭȯ¿ø°è
  • oxidation-reduction titration
    »êȭȯ¿øÀûÁ¤
  • proportional reduction
    ºñ·Ê°¨·Â
  • reduction potential
    ȯ¿øÀüÀ§
  • reduction
    ±³Á¤, ȯ¿ø, Ãà¼Ò
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reduction in area
    ´Ü¸é¼öÃà·ü(Ó¨Øüâ¥õêëÒ).
  • reduction of cardiac work load
    ½ÉÀÛ¾÷·®ÀÇ °æ°¨(ãýíÂåöåÖ¡­ÌîÊõ).
  • reduction of chromosome
    ¿°»öü°¨¼ö(æøßäô÷Êõâ¦).
  • reduction of fraction
    ¾àºÐ(å³ÝÂ).
  • reduction of fracture
    °ñÀý Á¤º¹(Íéï¹ïÚÜÖ).
  • reduction potential
    ȯ¿øÀüÀ§.
  • reduction rhinoplasty
    Ãà¼Òºñ¼ºÇü¼ú
  • reduction semiconductor
    ȯ¿øÇü¹ÝµµÃ¼(ü½êªû¡ÚâÓôô÷).
  • reduction test
    ȯ¿ø½ÃÇè.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hydrazine sulfate
    Ȳ»ê(üÜß«)È÷µå¶óÁø.
  • hyoscyamine sulfate
    Ȳ»êÈ÷¿À½º½Ã¾Æ¹Î.
  • lead sulfate
    Ȳ»ê(Ì·Ë×)³³.
  • magnesium sulfate
    Ȳ»ê(üÜß«)¸¶±×³×½·.
  • magnesium sulfate
    Ȳ»ê¸¶±×³×½·
  • protamine sulfate
  • serial dilution protamine sulfate test
    °è´ÜÈñ¼® ÇÁ·ÎŸ¹Î¼³ÆäÀÌÆ®½ÃÇè
  • sodium dodecyl sulfate
    ¼Òµð¿òµµµ¥½Ç¼³ÆäÀÌÆ®
  • sulfate
    Ȳ»ê¿°(üÜß«ç¤).
  • sulfate
    Ȳ»ê¿°(üÜß«ç¤)
  • zinc sulfate
    Ȳ»ê ¾Æ¿¬
  • zinc sulfate flotation procedure
    Ȳ»ê¾Æ¿¬ºÎ¾ç¹ý
  • closed reduction
    µµ¼öÁ¤º¹(Óùâ¢ïÚÜÙ), ºñ°üÇ÷Àû(°ñ)Á¤º¹¼ú(ުκúìîÜÍéïÚÜÖâú).
  • copper reduction test
    ±¸¸®È¯¿ø½ÃÇè
  • dose-reduction factor
    ¼±·®°¨¼Ò°è¼ö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • assimilatory reduction
    µ¿È­Àûȯ¿ø (ÔÒûùîÜü½êª)
  • biological oxidation-reduction
    »ýü »êȭȯ¿ø(ßæô÷ß«ûùü½êª)
  • carbon reduction cycle
    ź¼Ò ȯ¿ø ȸ·Î(÷©áÈü½êªüÞÖØ)
  • catalytic reduction method
    Ã˸Åȯ¿ø¹ý(õºØÚü½êªÛö)
  • dissimilatory reduction
    ÀÌÈ­ ȯ¿ø(ì¶ûùü½êª)
  • nitrate reduction
    Áú»êȯ¿ø(òòß«ü½êª)
  • oxidation-reduction enzyme
    »êȭȯ¿ø È¿¼Ò(ß«ûùü½êªý£áÈ)
  • oxidation-reduction potential
    »êȭȯ¿ø ÀüÀ§(ß«ûùü½êªï³êÈ)
  • oxidation-reduction reaction
    »êȭȯ¿ø ¹ÝÀÀ(ß«ûùü½êªÚãëë)
  • plaque reduction method
    ÇöóÅ© °¨¼Ò¹ý(Êõá´Ûö)
  • reduction
    "ȯ¿ø(ü½êª), °¨¼Ò(Êõá´)"
  • reduction division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ)
  • reduction phase
    ȯ¿ø±â(ü½êªÑ¢)
  • reduction potential
    ȯ¿ø ÀüÀ§(ü½êªï³êÈ)
  • respiratory reduction
    È£Èí¼º ȯ¿ø(û¼ýåàõü½êª)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OR   1) Operating Room; ¼ö¼ú½Ç
  2) Open Reduction
O/R Open Reduction
PRNT Plaque Reduction Neutrolization Test
ARA Academy of Rehabilitative Audiometry; acetylene reduction activity; American Rheumatism Association;...
CFR case-fatality ratio; citrovorum-factor rescue; Code of Federal Regulations; complement-fixation reac...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LRD Limb reduction defects
LVRS Lung Volume Reduction Surgery
LVR Lung volume reduction
MFPR Multifetal pregnancy reduction
ORIF Open reduction and internal fixation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • calcium sulfate
    Ȳ»ê Ä®½·
    õ¿¬ÀûÀ¸·Î¼­ ¼®°í CaSO4, 2H2O ¹× °æ¼®°í CaSO4·Î½á »êÃâ, ÀüÀÚ¸¦ Å¿ö¼­ CaSO4, 1/2H2OÀÇ ¼Ò¼®°í·Î¼­ »ç¿ëÇÑ´Ù. À̰Ϳ¡ ¹°À» °¡ÇÏ¿© Àλóü³»¿¡ ÁÖÀÔ½ÃŰ¸é ¼öºÐ¿¡¼­ 10ºÐ »çÀÌ¿¡ ¼®°í°¡ µÇ°í °æÈ­µÈ´Ù. ¼®°íÀÇ ¿ëÇØµµ´Â 42¡É·Î¼­ ÃÖ°íÀÌ´Ù. ¼®°í ¸ðÇü Á¦ÀÛ µî¿¡ »ç¿ëµÈ´Ù.
  • calcium sulfate bonded investment
    ¼®°í°è ¸Å¸ôÀç, ¼®°í °áÇÕ ¸Å¸ôÀç
  • calcium sulfate hemihydrate
    ¹Ý¼ö ¼®°í
    À̼ö ¼®°í¸¦ °¥¾Æ¼­ 230¡­248¢µÀÇ ¿Âµµ¸¦ °¡ÇÏ¸é °áÁ¤Ã¼ ÁßÀÇ ÀϺΰ¡ »ÀÀÚ ³ª°¡ Ä¡°ú¿ë °æ¼®°í°¡ µÈ´Ù. È­ÇÐ ±¸Á¶½Ä CaSO4, 1/2H2O.
  • copper sulfate test
    Ȳ»ê µ¿ °Ë»ç
  • dermatan sulfate
    ´õ¸¶Åº ¼³ÆäÀÌÆ®
  • ephedrine sulfate
    Ȳ»ê ¿¡Æäµå¸°
  • exsiccated magnesium sulfate
    °ÇÁ¶ Ȳ»ê ¸¶±×³×½·
    Ȳ»ê ¸¶±×³×½· ¼öÈ­¹°À» 100µµ¿¡¼­ °ÇÁ¶½ÃÄѼ­ 25% °¨·®½ÃŲ °Í.
  • heparin sulfate
    ÇìÆÄ¸° ¼³ÆäÀÌÆ®
    Ȳ»ê ÇìÆÄ¸®Æ¾.
  • hydrazine sulfate
    Ȳ»ê È÷µå¶óÁø
  • liquid ferrous sulfate
    ¾×ü Ȳ»ê Á¦1ö
  • sodium lauryl sulfate
    ¶ó¿ì¸± Ȳ»ê ³ªÆ®·ý
    À½À̿ ǥ¸é Ȱ¼ºÁ¦. ¹é»ö ¶Ç´Â ¹àÀº Ȳ»öÀÇ °áÁ¤. ½ÀÀ±Á¦, À¯È­ º¸Á¶Á¦, °¢Á¾ ¹Ì¿ë°ú ÇǺο¡ ´ëÇÑ ¼¼Á¤Á¦, Å©¸² Ä¡¾àÀÇ ¼ººÐÀ¸·Î »ç¿ëÇÑ´Ù.
  • sodium sulfate
    Ȳ»ê ³ªÆ®·ý
    ¹Ù·ý Áßµ¶¿¡ ´ëÇÑ ÇØµ¶Á¦ ¼³»ç ¾àÀ¸·Î »ç¿ëÇϸç, °¨¿°µÈ »óó¿¡ ´ëÇÑ ÃÖ¸²ÇÁ ¾àÀ¸·Î¼­ ±¹¼ÒÀûÀ¸·Î »ç¿ëÇϱ⵵ ÇÑ´Ù.
  • sodium tetradecyl sulfate
    Åׯ®¶óµ¥½ÇȲ»ê³ªÆ®·ý
    °æÈ­¼ºÀ» °®´Â À½À̿ °è¸éȰ¼ºÁ¦, ¹é»öÀÇ ¹Ð¶ø¼º °íü. ½ÀÀ±Á¦·Î¼­ ¾²À̸ç, Á¤¸Æ·ù¿Í Ä¡ÁúÀÇ Ä¡·á·Îµµ »ç¿ëÇÑ´Ù.
  • zinc sulfate
    Ȳ»ê ¾Æ¿¬
    ¹«»ö, Åõ¸íÇÑ °áÁ¤Ã¼, ZnSO
  • zinc sulfate flotation procedure
    Ȳ»ê ¾Æ¿¬ ºÎ¾ç¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
Schmorl's ferric-ferricyanide reduction stain <technique> A stain to test for reducing substances in tissues, including melanin, argentaffin granules, thyroid colloid, keratin, keratohyalin, and lipofuscin pigments; ferricyanide is converted into ferrocyanide which is converted to insoluble Prussian blue in the presence of ferric ions.
(05 Mar 2000)
selective reduction <obstetrics> A technique for intrauterine termination of one or more foetuses while leaving one or more foetuses undisturbed, usually in pregnancies with foetal anomalies or with multiple gestations.
(05 Mar 2000)
source emission reduction plan (SERP) A contingency plan developed to reduce emissions during an air quality emergency.
(05 Dec 1998)
nitroblue tetrazolium reduction <chemical> Nitroblue tetrazolium, a yellow dye, is taken up by phagocytosing neutrophils and reduced to insoluble formazan, which is deep blue, if the metabolic burst is normal. Reduction does not take place in chronic granulomatous disease.
(18 Nov 1997)
internal reduction The relocation of a joint or realignment of a fracture through a surgical incision. most internal reductions utilise general anaesthesia.
(27 Sep 1997)
open reduction of fractures Reduction by manipulation of bone, after incision in skin and muscle over the site of the fracture.
(05 Mar 2000)
oxidation-reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs.
(12 Dec 1998)
oxidation-reduction electrode An electrode capable of measuring oxidation-reduction potential.
See: quinhydrone electrode.
Synonym: redox electrode.
(05 Mar 2000)
oxidation-reduction indicator A substance that undergoes a definite colour change at a specific oxidation potential.
Synonym: redox indicator.
(05 Mar 2000)
oxidation-reduction potential <chemistry, physics> The potential in volts of an inert metallic electrode measured in a system of an arbitrarily chosen ratio of [oxidant] to [reductant] and referred to the normal hydrogen electrode at absolute temperature.
It is calculated from the following equation: where R is the gas constant expressed in electrical units, T the absolute temperature (Kelvin), n the number of electrons transferred, F the faraday and E0 the normal symbol for the potential of the system at pH 0; for biological systems E0' is often used (in which pH = 7).
Compare: Nernst's equation.
Synonym: redox potential.
(05 Mar 2000)
oxidation-reduction reaction <chemistry> Any reaction in which electrons are removed from one molecule or atom and given to another molecule or atom.
(09 Oct 1997)
oxidation-reduction system <enzyme> An enzyme system in the tissues by which oxidation and reduction proceed simultaneously through the transference of hydrogen or of one or more electrons from one metabolite to another.
See: oxidation-reduction.
Synonym: redox system.
(05 Mar 2000)
tuberosity reduction The surgical excision of excessive fibrous or bony tissue in the area of the maxillary tuberosity prior to the construction of prosthetic appliances.
(05 Mar 2000)
acid sulfate A salt containing HSO4-.
Synonym: acid sulfate.
(05 Mar 2000)
active sulfate 3'-phosphoadenosine 5'-phosphosulfate;an intermediate in the formation of urinary ethereal sulfates, notable for containing a "high energy" sulfate bond; the 3'-OH of adenosine is replaced by -OPO3H2, the 5'-OH by -OP(O2H)-OSO3H.
Synonym: active sulfate.
Acronym: PAPS
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á